Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats
- PMID: 10195162
- DOI: 10.1038/1105
Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats
Abstract
In vitro expansion of central nervous system (CNS) precursors might overcome the limited availability of dopaminergic neurons in transplantation for Parkinson's disease, but generating dopaminergic neurons from in vitro dividing precursors has proven difficult. Here a three-dimensional cell differentiation system was used to convert precursor cells derived from E12 rat ventral mesencephalon into dopaminergic neurons. We demonstrate that CNS precursor cell populations expanded in vitro can efficiently differentiate into dopaminergic neurons, survive intrastriatal transplantation and induce functional recovery in hemiparkinsonian rats. The numerical expansion of primary CNS precursor cells is a new approach that could improve both the ethical and the technical outlook for the use of human fetal tissue in clinical transplantation.
Comment in
-
Survival of expanded dopaminergic precursors is critical for clinical trials.Nat Neurosci. 1998 Nov;1(7):537. doi: 10.1038/2773. Nat Neurosci. 1998. PMID: 10196555 No abstract available.
Similar articles
-
Dopaminergic properties and function after grafting of attached neural precursor cultures.Neurobiol Dis. 2006 Mar;21(3):587-606. doi: 10.1016/j.nbd.2005.09.003. Epub 2005 Oct 26. Neurobiol Dis. 2006. PMID: 16256357
-
Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.Brain Res. 2008 Jul 7;1218:13-20. doi: 10.1016/j.brainres.2008.04.039. Epub 2008 Apr 26. Brain Res. 2008. PMID: 18513704
-
The controlled differentiation of human neural stem cells into TH-immunoreactive (ir) neurons in vitro.Neurosci Lett. 2005 Sep 30;386(2):105-10. doi: 10.1016/j.neulet.2005.04.065. Neurosci Lett. 2005. PMID: 16046065
-
Midbrain-derived neural stem cells: from basic science to therapeutic approaches.Cell Tissue Res. 2004 Oct;318(1):15-22. doi: 10.1007/s00441-004-0923-5. Epub 2004 Jul 29. Cell Tissue Res. 2004. PMID: 15503150 Review.
-
Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.Curr Opin Biotechnol. 2005 Oct;16(5):487-92. doi: 10.1016/j.copbio.2005.08.005. Curr Opin Biotechnol. 2005. PMID: 16143504 Review.
Cited by
-
Sequential actions of BMP receptors control neural precursor cell production and fate.Genes Dev. 2001 Aug 15;15(16):2094-110. doi: 10.1101/gad.894701. Genes Dev. 2001. PMID: 11511541 Free PMC article.
-
Impact of degradable macromer content in a poly(ethylene glycol) hydrogel on neural cell metabolic activity, redox state, proliferation, and differentiation.Tissue Eng Part A. 2010 Jun;16(6):1857-66. doi: 10.1089/ten.TEA.2009.0509. Tissue Eng Part A. 2010. PMID: 20067398 Free PMC article.
-
Stem cell biology and neurodegenerative disease.Philos Trans R Soc Lond B Biol Sci. 2004 May 29;359(1445):851-6. doi: 10.1098/rstb.2004.1472. Philos Trans R Soc Lond B Biol Sci. 2004. PMID: 15293812 Free PMC article. Review.
-
Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?J Neurol. 2011 May;258(Suppl 2):S346-53. doi: 10.1007/s00415-011-5974-4. J Neurol. 2011. PMID: 21437664
-
Study of effect of salvianolic acid B on motor function recovery in rats with spinal cord injury.Biomed Res Int. 2014;2014:931850. doi: 10.1155/2014/931850. Epub 2014 Mar 18. Biomed Res Int. 2014. Retraction in: Biomed Res Int. 2017;2017:8234878. doi: 10.1155/2017/8234878. PMID: 24757683 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources